Impact of pneumococcal vaccine on childhood pneumonia

肺炎球菌疫苗对儿童肺炎的影响

• 批准号: nhmrc : GNT1064841
• 负责人: A/Pr Stephen Lambert
• 金额: $ 109.1万
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/impact-pneumococcal-vaccine-childhood-pneumonia/1344877
• 关键词: Impact; pneumococcal; vaccine; childhood; pneumonia

Streptococcus pneumonia (Pneumococcus) is a bug that is a leading cause of childhood morbidity and mortality world-wide. Vaccinations have been recently brought onto the national immunisation program to try and combat this. This study aims to assess the new 13 valent Pneumococcal vaccine by studying its effectiveness in preventing childhood pneumonia in Australia by analysing the strains of Pneumococus in the blood and the fluid surrounding the lining the lung in complicated pneumonia using sensitive molecular techniques.

肺炎链球菌(肺炎球菌)是一种细菌，是全世界儿童发病率和死亡率的主要原因。最近，疫苗接种被纳入了国家免疫计划，以试图与此作斗争。这项研究旨在通过使用敏感的分子技术分析复杂肺炎患者血液和肺部衬里周围液体中的肺炎球菌菌株，通过研究其在预防澳大利亚儿童肺炎方面的有效性来评估新的13价肺炎疫苗。